Cure My Disease

Don't miss your cure!

 Log in / Sign up

Heart pacing showdown: new method vs. standard in 6,000 patients

NCT ID NCT06606288

Knowledge-focused Sponsor: Medtronic Cardiac Rhythm and Heart Failure Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at real-world data from 6,000 heart failure patients to compare a newer pacing method (conduction system pacing) with the standard method (biventricular pacing). The goal is to see if the newer approach is just as safe and effective at reducing heart failure hospitalizations. The study uses existing medical records, so no new treatments are given.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 6,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2017

Expected to finish

Dec 2030

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study cohort will include all U.S. Medicare beneficiaries enrolled in fee-for-service Medicare implanted with a Medtronic pacemaker between January 1, 2017 and December 1, 2023.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Dual-chamber CSP cohort: * Medicare beneficiaries implanted with a Medtronic dual-chamber transvenous pacemaker on or after the study start date. * Lead type and placement data indicating CSP. * An indication for CRT. BVP comparator cohort: * Medicare beneficiaries implanted with a Medtronic biventricular pacemaker (CRT-P) on or after the study start date. Exclusion Criteria: Dual-chamber CSP cohort: * Evidence of a prior CIED device. * Less than 12 months continuous enrollment in Medicare Part A and Part B prior to implant date. * Non-Medtronic pacemaker (unable to link to Medtronic device registration data). * Missing lead type or placement data. * Lead type and placement data indicating non-CSP placement. BVP comparator cohort: * Evidence of a prior CIED device. * Less than 12 months continuous enrollment in Medicare Part A and Part B prior to implant date. * Non-Medtronic pacemaker (unable to link to Medtronic device registration data). * Missing lead type or placement data.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Heart failure are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Heart failure

Contacts and locations

Locations

  • Medtronic

    Mounds View, Minnesota, 55112, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.